1AI — Algorae Pharmaceuticals Share News
0.000.00%
- AU$18.58m
- AU$16.69m
- AU$0.14m
Australia Stock Exchange release from LIVING CELL TECH : Chairman's Address to the General Meeting
Australia Stock Exchange release from LIVING CELL TECH : Non-Renounceable Rights Issue Opens
Australia Stock Exchange release from LIVING CELL TECH : Update - Proposed issue of securities - LCT
Australia Stock Exchange release from LIVING CELL TECH : Proposed issue of securities - LCT
Australia Stock Exchange release from LIVING CELL TECH : PRE_NR Ends: 09:46:06
Australia Stock Exchange release from LIVING CELL TECH : Prospectus- Rights Issue
Australia Stock Exchange release from LIVING CELL TECH : LCT- Rights Issue
Australia Stock Exchange release from LIVING CELL TECH : PRE_NR Ends: 09:42:26
Australia Stock Exchange release from LIVING CELL TECH : Results of Annual General Meeting
Australia Stock Exchange release from LIVING CELL TECH : CEO's presentation to AGM
Australia Stock Exchange release from LIVING CELL TECH : Chairman's Address to the 2021 Annual General Meeting
Australia Stock Exchange release from LIVING CELL TECH : PRE_NR Ends: 14:46:27
Australia Stock Exchange release from LIVING CELL TECH : LCT Receives New Zealand R&D Tax Credit
Australia Stock Exchange release from LIVING CELL TECH : PRE_NR Ends: 08:47:06
Australia Stock Exchange release from LIVING CELL TECH : LCT Advises Price Change for Rights Issue
Australia Stock Exchange release from LIVING CELL TECH : Quarterly Activity Report and Appendix 4C
Australia Stock Exchange release from LIVING CELL TECH : PRE_NR Ends: 09:17:24
Australia Stock Exchange release from LIVING CELL TECH : Notice of General Meeting/ Proxy Form
Brief: Living Cell Technologies Signs MoU With Nzeno, Secures Pig Cells For NTCELL Trial